Idiopathic and progressive pulmonary fibrosis (IPF/PPF) are severe interstitial lung diseases with poor prognoses and complex care needs. While guidelines focus on pharmacological treatment, patients’ overarching wishes are often neglected.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Idiopathic and progressive pulmonary fibrosis (IPF/PPF)
An instrument for clinical use
- Rosacea - multifaceted and multifactorial
Topical and systemic active ingredients: proven and new therapeutic approaches
- Lung cancer
Multidisciplinary teams in oncology
- From diagnostics to personalized therapy
Nuclear medical imaging for Parkinson’s disease
- Psoriasis in difficult localizations: Nail psoriasis
IL-23 and IL-17 as a target – selected study findings
- Artificial intelligence in diabetes prevention
Lifestyle interventions are better accepted with AI
- B-cell lymphomas
Bispecific antibodies – mechanisms, evidence and future role
- Dermatoscopic findings of granulomatous diseases